LARP7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.376220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.473000E-01
Normal-vs-Stage2
7.292000E-02
Normal-vs-Stage3
9.338400E-02
Normal-vs-Stage4
9.630200E-01
Stage1-vs-Stage2
3.187400E-01
Stage1-vs-Stage3
2.773600E-01
Stage1-vs-Stage4
4.740800E-01
Stage2-vs-Stage3
4.367400E-01
Stage2-vs-Stage4
3.389600E-02
Stage3-vs-Stage4
1.782790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.458750E-01
Normal-vs-AfricanAmerican
2.177200E-01
Normal-vs-Asian
1.386250E-01
Caucasian-vs-AfricanAmerican
9.622800E-01
Caucasian-vs-Asian
4.723600E-01
AfricanAmerican-vs-Asian
7.000600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.573800E-02
Normal-vs-Female
2.362200E-01
Male-vs-Female
5.848000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.112000E-01
Normal-vs-Age(41-60Yrs)
2.431600E-01
Normal-vs-Age(61-80Yrs)
1.089630E-01
Normal-vs-Age(81-100Yrs)
1.974400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.400200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.404000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.159200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.595700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.771600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.607000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.100050E-02
Normal-vs-Daily Drinker
6.107500E-02
Normal-vs-Weekly Drinker
1.517410E-01
Normal-vs-Occasional Drinker
3.460600E-01
Normal-vs-Social Drinker
3.506200E-01
Non Drinker-vs-Daily Drinker
5.445000E-01
Non Drinker-vs-Weekly Drinker
6.711000E-01
Non Drinker-vs-Occasional Drinker
2.990300E-02
Non Drinker-vs-Social Drinker
4.103500E-02
Daily Drinker-vs-Weekly Drinker
9.855600E-01
Daily Drinker-vs-Occasional Drinker
1.555950E-01
Daily Drinker-vs-Social Drinker
1.852810E-01
Weekly Drinker-vs-Occasional Drinker
2.695400E-01
Weekly Drinker-vs-Social Drinker
3.044600E-01
Occasional Drinker-vs-Social Drinker
9.804600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.091000E-01
Normal-vs-Grade 2
5.046000E-01
Normal-vs-Grade 3
5.046100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.474200E-01
Grade 1-vs-Grade 3
9.232000E-01
Grade 1-vs-Grade 4
2.091000E-01
Grade 2-vs-Grade 3
7.613200E-01
Grade 2-vs-Grade 4
5.046000E-01
Grade 3-vs-Grade 4
5.046100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.134200E-02
Normal-vs-NonDiabetic
1.212200E-01
Diabetic-vs-NonDiabetic
2.581400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.130300E-02
Normal-vs-NoPancreatitis
1.130450E-01
Pancreatitis-vs-NoPancreatitis
5.814200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.639800E-01
Normal-vs-N1
7.343700E-02
N0-vs-N1
2.512400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.051400E-01
Normal-vs-TP53-NonMutant
4.754000E-01
TP53-Mutant-vs-TP53-NonMutant
7.702800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
